179 related articles for article (PubMed ID: 19208889)
21. Mycobacterium kansasii.
Johnston JC; Chiang L; Elwood K
Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185617
[TBL] [Abstract][Full Text] [Related]
22. [Arthritis due to Mycobacterium kansasii in a woman with human immunodeficiency virus infection].
Puerto JL; García-Martos P; Saldarreaga A; Ruiz-Aragón J; Mira J
Enferm Infecc Microbiol Clin; 2007 Apr; 25(4):289. PubMed ID: 17386226
[No Abstract] [Full Text] [Related]
23. An unusual lung mass post stem cell transplantation.
Lyons J; Vandenberghe E; Fahy R; McDonnell C; Keane J; McLaughlin AM
Transpl Infect Dis; 2014 Aug; 16(4):672-5. PubMed ID: 24995624
[TBL] [Abstract][Full Text] [Related]
24. [THE GENETIC EXAMINATION OF BRONCHIAL LAVAGE ENABLES THE PROMPT DIAGNOSIS OF PULMONARY MYCOBACTERIUM KANSASII--A CASE REPORT].
Mori M; Ageshio F; Kagawa H; Oshitani Y; Fujikawa T; Saito H; Sako H; Yano Y; Kitada S; Maekura R
Kekkaku; 2015 Aug; 90(8):619-23. PubMed ID: 26665518
[TBL] [Abstract][Full Text] [Related]
25. Mycobacterium marinum infection after infliximab therapy.
Alkhawaja S; Tammam N; Khalifa N
Iran J Allergy Asthma Immunol; 2010 Dec; 9(4):255-7. PubMed ID: 21131707
[TBL] [Abstract][Full Text] [Related]
26. Nontuberculous mycobacterial olecranon bursitis: case reports and literature review.
Garrigues GE; Aldridge JM; Toth AP; Stout JE
J Shoulder Elbow Surg; 2009; 18(2):e1-5. PubMed ID: 19019704
[No Abstract] [Full Text] [Related]
27. Fisherman's Dilemma: Disseminated Mycobacterium marinum in an Immunosuppressed Patient.
Khan UM; Rittenberg A
Am J Med; 2020 Oct; 133(10):e549-e551. PubMed ID: 32087106
[No Abstract] [Full Text] [Related]
28. Rapid improvement of Mycobacterium kansasii pneumonia after rifabutin, isoniazid, and ethambutol: A case report.
Kuo HI; Huang ST; Wu YH
Kaohsiung J Med Sci; 2022 Nov; 38(11):1137-1138. PubMed ID: 36254860
[No Abstract] [Full Text] [Related]
29. Treatment alternatives for Mycobacterium kansasii.
Graybill JR; Bocanegra R
J Antimicrob Chemother; 2001 Apr; 47(4):417-20. PubMed ID: 11266413
[TBL] [Abstract][Full Text] [Related]
30. Tenosynovitis of the right hand. Mycobacterium kansasii.
Formanoy E; Lam HY; Arends JE
Neth J Med; 2013 Dec; 71(10):526, 530. PubMed ID: 24394739
[No Abstract] [Full Text] [Related]
31. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.
Evans SA; Colville A; Evans AJ; Crisp AJ; Johnston ID
Thorax; 1996 Dec; 51(12):1248-52. PubMed ID: 8994524
[TBL] [Abstract][Full Text] [Related]
32. Infliximab for life-threatening pulmonary artery aneurysms in Behçet's disease. A case report.
Tolosa-Vilella C; Capela CA; Monteagudo-Jiménez M; Marí-Alfonso B
Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S94-5. PubMed ID: 21385550
[No Abstract] [Full Text] [Related]
33. Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.
Leccese P; Latanza L; D'Angelo S; Padula A; Olivieri I
Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S93. PubMed ID: 21813069
[No Abstract] [Full Text] [Related]
34. Successful use of infliximab in a patient with neuro-Behçet's disease.
Abalos-Medina GM; Sánchez-Cano D; Ruiz-Villaverde G; Ruiz-Villaverde R; Quirosa Flores S; Raya Alvarez E
Int J Rheum Dis; 2009 Sep; 12(3):264-6. PubMed ID: 20374357
[TBL] [Abstract][Full Text] [Related]
35. Ethambutol-induced bullous skin lesions in
Kollipara VK; Horowitz M; Lantz J; Nagy-Agren S
Int J Mycobacteriol; 2022; 11(1):120-122. PubMed ID: 35295035
[TBL] [Abstract][Full Text] [Related]
36. Mycobacterium marinum infection in an immunocompromised patient with infliximab.
Zimmerlich S; Eder IB; Simon JC; Kunz M
Eur J Dermatol; 2020 Aug; 30(4):436-437. PubMed ID: 32969808
[No Abstract] [Full Text] [Related]
37. Central nervous system infection and cutaneous lymphadenitis due to Mycobacterium kansasii in an immunocompetent patient.
Tabatabaei N; Stout J; Goldschmidt-Clermont P; Murdoch D
Infection; 2007 Jun; 35(4):291-4. PubMed ID: 17646914
[No Abstract] [Full Text] [Related]
38. Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody.
Travis SP; Czajkowski M; McGovern DP; Watson RG; Bell AL
Gut; 2001 Nov; 49(5):725-8. PubMed ID: 11600479
[TBL] [Abstract][Full Text] [Related]
39. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
[TBL] [Abstract][Full Text] [Related]
40. Cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for Behcet's disease.
Kluger N; Poirier P; Guilpain P; Baixench MT; Cohen P; Paugam A
Int J Infect Dis; 2009 Sep; 13(5):e325. PubMed ID: 19157948
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
